Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the United States and internationally. Founded in 1967 and based in Secaucus, ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...

Looking ahead, industry tailwinds include the expansion of personalized medicine ... Founded in 1967 as MetPath, Quest Diagnostics (NYSE:DGX) is a provider of diagnostic testing services, offering ...

(RTTNews) - Quest Diagnostics (DGX) reaffirmed its guidance for full year 2025. The company continues to project: adjusted EPS in a range of $9.55 to $9.80, and net revenues in a range of $10.70 ...

Looking ahead, industry tailwinds include the expansion of personalized medicine, increased adoption of at-home and rapid diagnostic tests, and advancements in AI-driven diagnostics that enhance ...